Konsul'tirovanie po primeneniyu levonorgestrelvydelyayushchey vnutrimatochnoy sistemy "Mirena"


如何引用文章

全文:

详细

Левоноргестрелвыделяющая внутриматочная система "Мирена" (ЛНГ ВМС) была разработана (Лейрас АО, Турку, Финляндия) как средство для пролонгированной, обратимой контрацепции, сочетающее преимущества внутриматочного и гормонального методов предохранения от беременности. Консультирование о применении внутриматочной системы "Мирена" должно включать информацию не только о контрацептивном, но и неконтрацептивных преимуществах метода.

作者简介

M Tarasova

НИИ акушерства и гинекологии им. Д.О.Отта РАМН, Санкт-Петербург

V Grigor'eva

НИИ акушерства и гинекологии им. Д.О.Отта РАМН, Санкт-Петербург

参考

  1. Pakarinen P, Toivonen J, Luukkainen T. Therapeutic Use of the LNG IDS, and Counseling. Seminars in reproductive medicine/volume 19, number 4 2001; 365–72.
  2. Nilsson C.G, Lahteenmaki P.L, Luukkainen T. Ovarian function in amenorrheic and menstruating users of a levonorgestrel - releasing intrauterine device. Fertil Steril 1984; 41: 52–SS.
  3. Barbosa I, Bakos O, Olsson S.E et al. Ovarian function during use of a levonorgestrel - releasing IUD. Contraception 1990; 42: 51–66.
  4. Andersson K, Mattsson L-O, Rybo G, Stanberg E. Intrauterine release of levonorgestrel: a new way of adding progestogen in hormone replacement therapy. Obstet Gynecol 1992; 79: 963–7.
  5. Faundes A, Alvarez F, Diaz J. A Latin American experience with levonorgestrel IUD. Ann Med 1993; 25: 149–53.
  6. Sivin I, Alvarez F, Diaz J et al. Intrauterine contraception with qt copper and with levonorgestrel: a randomised study of the Tcu380Ag and levonorgestrel 20 ug/D devices. Contraception 1984; 30: 443–56.
  7. Lei Z-W, Wu S.C, Garceau R.J et al. Effects of pretreatment counseling on discontinuation rates in Chinese women given depo - meclroxyprogesterone acetate for contraception. Contraception 1996; 53: 357–61.
  8. Luukkainen T, Lahteenmaki P, Toivonen J. Three years' experience with levonorgestrel - releasing intrauterine device and Norplant-2 implants: a randomized comparative study. Adv Contracept 1992; 8: 105–14.
  9. Nilsson C.G, Luukkainen T, Arko H. Endometrial morphology of women using a d - norgesrrel - releasing intrauterine device. Fertil Steril 1978; 29: 397–401,
  10. Silverberg S.G, Haukkamaa M, Arko H et al. Endometrial morphology during long - term use of levonorgestrel - releasing intrauterine devices. Int J Gynecol Pathol 1986; 3: 235–41.
  11. Jones R.L, Critchley H.O. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 2000; 15 (suppl. 3): 162–72.
  12. Rutanen E-M. Insulin - like growth factors and insulin - like growth factor binding proteins in the endometrium: effect of intrauterine levonorgestrel delivery. Hum Reprod 2000; 15 (suppl. 3): 173–81.
  13. Andersson J.K, Rybo G. Levonorgestrel - releasing intrauterine device in the treatment of menorrhagia. Br J Obstet Gynaecol 1990; 97: 690–4.
  14. Milsora I, Andersson K, Andersch B, Rybo G. A comparison of flurbiprofen, tranexamic acid and a levonorgestrel - releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991; 164: 879–83.
  15. Tang G.W, Loa S.S. Levonorgestrel intrauterine device in the treatment of menorrhagia in Chinese women: efficacy versus acceptability. Contraception 1995; 51: 231–5.
  16. Kittelsen N, Istre О.A. A randomized study comparing levonorgestrel intrauterine system (LNG IUS) and transcervical resection of the endometrium (TRCE) in the treatment of menorrhagia: preliminary results. Gynaecol Endoscopy 1998; 7: 61–5.
  17. Hurskainen R, Teperi J, Rissanen P et al. Quality of life and cost - effectiveness of levonorgestrel - releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomized trial. Lancet 2001; 357: 273–7.
  18. Lahteenmaki P, Haukkamaa M, Puolakka J et al. Open randomized study of use of levonorgestrel intrauterine system as alternative to hysterectomy. BMJ 1998; 316: 112–6.
  19. Lethaby A.E, Cooke I, Rees M. Progesterone/progestogen-AQ2 releasing intrauterine systems versus either placebo or any AQ2 other medication for heavy menstrual bleeding. Cochrane Database Syst Rev 2000; 2: CD002126.
  20. Stewart A, Cummins C, Gold L et al. The effectiveness of the levonorgestrel - releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001; 108: 74–86.
  21. Hallberg L, Hogdahl A.M, Nilsson L, Rybo G. Menstrual blood loss: a population study. Acta Obstet Gynecol Scand 1966; 45: 320–51.
  22. Cohen B.J, Gibor Y Anemia and menstrual blood loss. Obstet Gynecol Surv 1980; 35: 597–618.
  23. Andersson K, Odlind V, Rybo G. Levonorgestrel - releasing and Ш copper - releasing (NovaT) IUDs during five years of use: a randomized comparative trial. Contraception 1994; 49: 56–72.
  24. Faundes A, Alvarez F, Brache V, Tejada A.S. The role of the levonorgestrel IUD in the prevention and treatment of iron deficiency anemia during fertility regulation. Int J Gynecol Obstet 1988; 26: 429–33.
  25. Luukkainen T, Allonen H, Haukkamaa M et al. Effective contraception with the levonorgestrel - releasing intrauterine device: 12-month report of a European multicenter study. Contraception 1987; 36: 169–79.
  26. Barrington J.W, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997; 104: 614–6.
  27. Jones R.L, Critchley H.O. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery. Hum Reprod 2000; 15 (suppl. 3): 162–72.
  28. Scholten P.C. The Levonorgestrel IUD: Clinical Performance and Impact on Menstruation [dissertation]. Utrecht, The Netherlands: 1989.
  29. Pike M.C, Ross R.K. Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer. Steroids 2000; 65: 659–64.
  30. Schairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen - progestin replacement therapy and breast cancer risk. JAMA 2000; 283: 485–91.
  31. Raudaskoski T.H, Lahti E.l, Kauppila A.J et al. Transdermal estrogen with a levonorgestrel - releasing intrauterine device for climacteric complaints: clinical and endometrial response. Am J Obstet Gynecol 1995; 172: 114–9.
  32. Vercellini P, Aimi G, Panazza S.J et al. A levonorgestrel - releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study. Fertil Steril 1999; 72: 505–8.
  33. Fedele L, Bianchi S, Zanconato G et al. Use of a levonorgestrel - releasing intrauterine device in the treatment of rectovaginal endometriosis. Fertil Steril 2001; 75: 485–8.
  34. Fedele L, Bianchi S, Raffaelli R et al. Treatment of adenomyosis - associated menorrhagia with a levonorgestrel - releasing intrauterine device. Fertil Steril 1997; 68: 426–9.
  35. Fong Y.F, Singh K. Medical treatment of a grossly enlarged ade - rb nomyotic uterus with the levonorgestrel - releasing intrauterine system. Contraception 1999; 60: 173–5.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2004

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).